News

Name: Cordis
Price range: $

Mar 4, 2026

Cordis to Present SELUTION SLR ™ DEB Clinical Data at CRT 2026

Presentations Include 12-Month Outcomes from the SELUTION4ISR Trial and the SELUTION DeNovo Trial in Coronary Lesions, Alongside Analyses on How Procedural Experience Influences Treatment Strategy.

Oct 20, 2025

Cordis Unveils Positive Results for Two SELUTON SLR DEB Trials

Cordis Unveiled Breakthrough Results from SELUTION DENOVO and SELUTION4ISR Trials at TCT 2025.

Oct 20, 2025

Cordis to Unveil 12-Month SELUTION SLR DEB Trial Results

Cordis to unveil 12-month results from two SELUTION SLR^™ DEB randomized clinical trials at TCT 2025 Late-Breaking Clinical Trials Session

May 19, 2025

Cordis Launches Global Coronary Registry for SELUTION SLR™ Drug-Eluting Balloon

This Global Coronary Registry will enroll up to 10,000 patients worldwide and will be one of the largest coronary drug-eluting balloon registries to date.

Apr 24, 2025

Cordis Announces Positive Results from Two Major Clinical Studies.

Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients.

Jun 18, 2024